U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill
Go back to U.S. FDA panel narrowly backs Merck's at-home COVID-19 pill| Merck & Co. (NYSE: MRK) | Delayed: 146.42 -0.73 (0.5%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $147.15 | 52 Week High | $65.46 | |||
| Open | $147.08 | 52 Week Low | $47.97 | |||
| Day High | $147.84 | P/E | 99.61 | |||
| Day Low | $145.74 | EPS | $1.47 | |||
| Volume | 4,583,983 | |||||
